An illustration of the potential for mapping MRI/MRS parameters with genetic over-expression profiles in human prostate cancer

Robert E. Lenkinski, B. Nicolas Bloch, Fangbing Liu, John V. Frangioni, Sven Perner, Mark A. Rubin, Elizabeth M. Genega, Neil M. Rofsky, Sandra M. Gaston

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Introduction: Magnetic resonance imaging (MRI) and MR spectroscopy can probe a variety of physiological (e.g. blood vessel permeability) and metabolic characteristics of prostate cancer. However, little is known about the changes in gene expression that underlie the spectral and imaging features observed in prostate cancer. Tumor induced changes in vascular permeability and angiogenesis are thought to contribute to patterns of dynamic contrast enhanced (DCE) MRI images of prostate cancer even though the genetic basis of tumor vasculogenesis is complex and the specific mechanisms underlying these DCEMRI features have not yet been determined. Materials and Methods: In order to identify the changes in gene expression that correspond to MRS and DCEMRI patterns in human prostate cancers, we have utilized tissue print micropeel techniques to generate "whole mount" molecular maps of radical prostatectomy specimens that correspond to pre-surgical MRI/MRS studies. These molecular maps include RNA expression profiles from both Affymetrix GeneChip microarrays and quantitative reverse transcriptase PCR (qrt-PCR) analysis, as well as immunohistochemical studies. Results: Using these methods on patients with prostate cancer, we found robust over-expression of choline kinase a in the majority of primary tumors. We also observed overexpression of neuropeptide Y (NPY), a newly identified angiogenic factor, in a subset of prostate cancers, visualized on DCEMRI. Conclusion: These studies set the stage for establishing MRI/MRS parameters as validated biomarkers for human prostate cancer.

Original languageEnglish (US)
Pages (from-to)411-421
Number of pages11
JournalMagnetic Resonance Materials in Physics, Biology and Medicine
Volume21
Issue number6
DOIs
StatePublished - Nov 2008

Fingerprint

Prostatic Neoplasms
Magnetic Resonance Imaging
Magnetic Resonance Spectroscopy
Choline Kinase
Gene Expression
Neoplasms
Angiogenesis Inducing Agents
Neuropeptide Y
Capillary Permeability
Prostatectomy
Reverse Transcriptase Polymerase Chain Reaction
Blood Vessels
Permeability
Biomarkers
RNA

Keywords

  • Gene expression
  • MRI
  • Prostate
  • Prostate cancer

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

An illustration of the potential for mapping MRI/MRS parameters with genetic over-expression profiles in human prostate cancer. / Lenkinski, Robert E.; Bloch, B. Nicolas; Liu, Fangbing; Frangioni, John V.; Perner, Sven; Rubin, Mark A.; Genega, Elizabeth M.; Rofsky, Neil M.; Gaston, Sandra M.

In: Magnetic Resonance Materials in Physics, Biology and Medicine, Vol. 21, No. 6, 11.2008, p. 411-421.

Research output: Contribution to journalArticle

Lenkinski, Robert E. ; Bloch, B. Nicolas ; Liu, Fangbing ; Frangioni, John V. ; Perner, Sven ; Rubin, Mark A. ; Genega, Elizabeth M. ; Rofsky, Neil M. ; Gaston, Sandra M. / An illustration of the potential for mapping MRI/MRS parameters with genetic over-expression profiles in human prostate cancer. In: Magnetic Resonance Materials in Physics, Biology and Medicine. 2008 ; Vol. 21, No. 6. pp. 411-421.
@article{0f5b34a5aa4840928d4976ec23560433,
title = "An illustration of the potential for mapping MRI/MRS parameters with genetic over-expression profiles in human prostate cancer",
abstract = "Introduction: Magnetic resonance imaging (MRI) and MR spectroscopy can probe a variety of physiological (e.g. blood vessel permeability) and metabolic characteristics of prostate cancer. However, little is known about the changes in gene expression that underlie the spectral and imaging features observed in prostate cancer. Tumor induced changes in vascular permeability and angiogenesis are thought to contribute to patterns of dynamic contrast enhanced (DCE) MRI images of prostate cancer even though the genetic basis of tumor vasculogenesis is complex and the specific mechanisms underlying these DCEMRI features have not yet been determined. Materials and Methods: In order to identify the changes in gene expression that correspond to MRS and DCEMRI patterns in human prostate cancers, we have utilized tissue print micropeel techniques to generate {"}whole mount{"} molecular maps of radical prostatectomy specimens that correspond to pre-surgical MRI/MRS studies. These molecular maps include RNA expression profiles from both Affymetrix GeneChip microarrays and quantitative reverse transcriptase PCR (qrt-PCR) analysis, as well as immunohistochemical studies. Results: Using these methods on patients with prostate cancer, we found robust over-expression of choline kinase a in the majority of primary tumors. We also observed overexpression of neuropeptide Y (NPY), a newly identified angiogenic factor, in a subset of prostate cancers, visualized on DCEMRI. Conclusion: These studies set the stage for establishing MRI/MRS parameters as validated biomarkers for human prostate cancer.",
keywords = "Gene expression, MRI, Prostate, Prostate cancer",
author = "Lenkinski, {Robert E.} and Bloch, {B. Nicolas} and Fangbing Liu and Frangioni, {John V.} and Sven Perner and Rubin, {Mark A.} and Genega, {Elizabeth M.} and Rofsky, {Neil M.} and Gaston, {Sandra M.}",
year = "2008",
month = "11",
doi = "10.1007/s10334-008-0133-3",
language = "English (US)",
volume = "21",
pages = "411--421",
journal = "Magnetic Resonance Materials in Physics, Biology, and Medicine",
issn = "1352-8661",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - An illustration of the potential for mapping MRI/MRS parameters with genetic over-expression profiles in human prostate cancer

AU - Lenkinski, Robert E.

AU - Bloch, B. Nicolas

AU - Liu, Fangbing

AU - Frangioni, John V.

AU - Perner, Sven

AU - Rubin, Mark A.

AU - Genega, Elizabeth M.

AU - Rofsky, Neil M.

AU - Gaston, Sandra M.

PY - 2008/11

Y1 - 2008/11

N2 - Introduction: Magnetic resonance imaging (MRI) and MR spectroscopy can probe a variety of physiological (e.g. blood vessel permeability) and metabolic characteristics of prostate cancer. However, little is known about the changes in gene expression that underlie the spectral and imaging features observed in prostate cancer. Tumor induced changes in vascular permeability and angiogenesis are thought to contribute to patterns of dynamic contrast enhanced (DCE) MRI images of prostate cancer even though the genetic basis of tumor vasculogenesis is complex and the specific mechanisms underlying these DCEMRI features have not yet been determined. Materials and Methods: In order to identify the changes in gene expression that correspond to MRS and DCEMRI patterns in human prostate cancers, we have utilized tissue print micropeel techniques to generate "whole mount" molecular maps of radical prostatectomy specimens that correspond to pre-surgical MRI/MRS studies. These molecular maps include RNA expression profiles from both Affymetrix GeneChip microarrays and quantitative reverse transcriptase PCR (qrt-PCR) analysis, as well as immunohistochemical studies. Results: Using these methods on patients with prostate cancer, we found robust over-expression of choline kinase a in the majority of primary tumors. We also observed overexpression of neuropeptide Y (NPY), a newly identified angiogenic factor, in a subset of prostate cancers, visualized on DCEMRI. Conclusion: These studies set the stage for establishing MRI/MRS parameters as validated biomarkers for human prostate cancer.

AB - Introduction: Magnetic resonance imaging (MRI) and MR spectroscopy can probe a variety of physiological (e.g. blood vessel permeability) and metabolic characteristics of prostate cancer. However, little is known about the changes in gene expression that underlie the spectral and imaging features observed in prostate cancer. Tumor induced changes in vascular permeability and angiogenesis are thought to contribute to patterns of dynamic contrast enhanced (DCE) MRI images of prostate cancer even though the genetic basis of tumor vasculogenesis is complex and the specific mechanisms underlying these DCEMRI features have not yet been determined. Materials and Methods: In order to identify the changes in gene expression that correspond to MRS and DCEMRI patterns in human prostate cancers, we have utilized tissue print micropeel techniques to generate "whole mount" molecular maps of radical prostatectomy specimens that correspond to pre-surgical MRI/MRS studies. These molecular maps include RNA expression profiles from both Affymetrix GeneChip microarrays and quantitative reverse transcriptase PCR (qrt-PCR) analysis, as well as immunohistochemical studies. Results: Using these methods on patients with prostate cancer, we found robust over-expression of choline kinase a in the majority of primary tumors. We also observed overexpression of neuropeptide Y (NPY), a newly identified angiogenic factor, in a subset of prostate cancers, visualized on DCEMRI. Conclusion: These studies set the stage for establishing MRI/MRS parameters as validated biomarkers for human prostate cancer.

KW - Gene expression

KW - MRI

KW - Prostate

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=57449120305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57449120305&partnerID=8YFLogxK

U2 - 10.1007/s10334-008-0133-3

DO - 10.1007/s10334-008-0133-3

M3 - Article

VL - 21

SP - 411

EP - 421

JO - Magnetic Resonance Materials in Physics, Biology, and Medicine

JF - Magnetic Resonance Materials in Physics, Biology, and Medicine

SN - 1352-8661

IS - 6

ER -